US Patent Issued to AGENSYS, SEAGEN on March 25 for "Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof" (American, Swiss Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,340, issued on March 25, was assigned to AGENSYS INC. (Northbrook, Ill.) and SEAGEN INC. (Bothell, Wash.).

"Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof" was invented by Orla McGarvey (Basel, Switzerland), Gayathri Ratnaswamy (Encino, Calif.), Yingqing Sun (San Diego) and Marie Rose Van Schravendijk (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition comprising an antibody drug conjugate comprising an antibody or antigen binding fragment thereof that binds to 191P4D12 conjugated to one or more units of monomethyl auristatin E (MMAE) and a pharmaceutically a...